小容量采血管减少重症监护输血:STRATUS随机临床试验
该阶梯楔形整群随机试验在加拿大25个成人内外科ICU中比较标准容量与小容量采血管对红细胞输注的影响。主要分析21 201例患者中,每患者每ICU住院红细胞输注单位无显著差异(RR 0.91,95%CI 0.79-1.05,P=0.19);预设次要分析27 411例中,小容量管组红细胞输注单位减少(RR 0.88,95%CI 0.77-1.00,P=0.04)。作者认为ICU使用小容量采血管可能减少红细胞输注而不影响实验室分析。
要点
- 主要分析中,标准容量管与小容量管组每患者每ICU住院红细胞输注单位无显著差异(RR 0.91,95%CI 0.79-1.05,P=0.19)。
- 预设次要分析中,小容量管组红细胞输注单位较标准容量管组减少(RR 0.88,95%CI 0.77-1.00,P=0.04)。
- 采血量不足的标本在转换前后均罕见(≤0.03%)。
核心结论
- ICU使用小容量采血管可能减少红细胞输注而不影响实验室分析。
研究设计与样本
- 在加拿大25个成人内外科ICU进行的阶梯楔形整群随机试验,时间为2019年2月5日至2021年1月21日。
- ICU随机从标准容量采血管(n=10 940)转换为小容量采血管(n=10 261)进行实验室检测。
- 主要分析纳入入住48小时及以上的患者,排除5.5个月COVID-19相关试验暂停期间入院的患者,共21 201例(平均年龄63.5岁,女性39.9%)。
- 预设次要分析纳入27 411例患者。
主要发现
- 主要分析中,每患者每ICU住院红细胞输注单位无显著差异(RR 0.91,95%CI 0.79-1.05,P=0.19;绝对减少7.24红细胞单位/100患者每ICU住院,95%CI -3.28至19.44)。
- 预设次要分析中,从标准容量转换为小容量采血管后,每患者每ICU住院红细胞输注单位减少(RR 0.88,95%CI 0.77-1.00,P=0.04;绝对减少9.84红细胞单位/100患者每ICU住院,95%CI 0.24至20.76)。
- 主要人群中,输血调整后血红蛋白中位下降无统计学差异(平均差0.10 g/dL,95%CI -0.04至0.23);次要人群中较低(平均差0.17 g/dL,95%CI 0.05至0.29)。
- 采血量不足无法分析的标本在转换前后均罕见(≤0.03%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Blood collection for laboratory testing in intensive care unit (ICU) patients is a modifiable contributor to anemia and red blood cell (RBC) transfusion. Most blood withdrawn is not required for analysis and is discarded. OBJECTIVE: To determine whether transitioning from standard-volume to small-volume vacuum tubes for blood collection in ICUs reduces RBC transfusion without compromising laboratory testing procedures. DESIGN, SETTING, AND PARTICIPANTS: Stepped-wedge cluster randomized trial in 25 adult medical-surgical ICUs in Canada (February 5, 2019 to January 21, 2021). INTERVENTIONS: ICUs were randomized to transition from standard-volume (n = 10 940) to small-volume tubes (n = 10 261) for laboratory testing. MAIN OUTCOMES AND MEASURES: The primary outcome was RBC transfusion (units per patient per ICU stay). Secondary outcomes were patients receiving at least 1 RBC transfusion, hemoglobin decrease during ICU stay (adjusted for RBC transfusion), specimens with insufficient volume for testing, length of stay in the ICU and hospital, and mortality in the ICU and hospital. The primary analysis included patients admitted for 48 hours or more, excluding those admitted during a 5.5-month COVID-19-related trial hiatus. RESULTS: In the primary analysis of 21 201 patients (mean age, 63.5 years; 39.9% female), which excluded 6210 patients admitted during the early COVID-19 pandemic, there was no significant difference in RBC units per patient per ICU stay (relative risk [RR], 0.91 [95% CI, 0.79 to 1.05]; P = .19; absolute reduction of 7.24 RBC units/100 patients per ICU stay [95% CI, -3.28 to 19.44]). In a prespecified secondary analysis (n = 27 411 patients), RBC units per patient per ICU stay decreased after transition from standard-volume to small-volume tubes (RR, 0.88 [95% CI, 0.77 to 1.00]; P = .04; absolute reduction of 9.84 RBC units/100 patients per ICU stay [95% CI, 0.24 to 20.76]). Median decrease in transfusion-adjusted hemoglobin was not statistically different in the primary population (mean difference, 0.10 g/dL [95% CI, -0.04 to 0.23]) and lower in the secondary population (mean difference, 0.17 g/dL [95% CI, 0.05 to 0.29]). Specimens with insufficient quantity for analysis were rare (≤0.03%) before and after transition. CONCLUSIONS AND RELEVANCE: Use of small-volume blood collection tubes in the ICU may decrease RBC transfusions without affecting laboratory analysis. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03578419.
引用
- Siegal DM, Belley-Côté EP, Lee SF, et al. Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial. JAMA. 2023. PMID: 37824152. doi:10.1001/jama.2023.20820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。